Two cases of allergic reactions with Pfizer COVID-19 vaccines in UK

Two cases of allergic reactions with Pfizer COVID-19 vaccines in UK

Two cases of allergic reactions with Pfizer COVID-19 vaccines in UK. The NHS does not recommend vaccination for people with a history of severe allergies.

According to reports from Columbia News Network and many other media, two British medical staff experienced allergic reactions after being vaccinated with Pfizer’s COVID-19 vaccine. The British National Health Service (NHS) warned that people with a history of obvious allergic reactions to vaccines, drugs and food are not recommended.

On Tuesday, the United Kingdom became the first country to initiate a large-scale vaccination program. Thousands of people have been vaccinated in 70 hospitals, and no major adverse drug reactions have been reported.

Stephen Powis, the medical director of the British NHS, pointed out in a statement that the two medical staff who were allergic to vaccines had previously had a history of “strong” allergic reactions, and the two have now recovered from vaccine allergies. As with any newly marketed vaccine, the British Medicines Regulatory Agency (MHRA) recommends that people with a history of obvious allergic reactions should not be vaccinated. At the same time, the recommendation says that vaccines can only be vaccinated in institutions with rescue and resuscitation measures.

According to currently available information, Pfizer vaccine contains the active substance BNT162b2, as well as a series of other auxiliary components. The specific cause and nature of the allergic reaction are still unclear. An MHRA spokesperson stated that the two case reports are being fully investigated.

In an interview with The Mirror, Dr. Kat Basford, a Zava online doctor, said that ordinary people can be safely vaccinated and the risk of allergic reactions is small. If you are worried about allergies, you can communicate with your doctor in advance. If a person has a history of allergic reactions, it is best to vaccinate in some hospitals with better emergency response capabilities. In the event of an allergic reaction to a vaccine, all the staff of the vaccination agency have received allergic reaction management training, and they can use first-aid equipment and drugs for rapid treatment.

According to current news, the first batch of vaccines in the UK totals 800,000 doses, which will be given priority to inpatients over 80 years of age and patients planning outpatient surgery, nursing home staff, NHS medical staff, especially vaccinating staff. Once these high-risk groups are licensed for vaccination, they can be vaccinated in various hospitals. The UK will receive a large number of Pfizer vaccines next week, and the NHS plans to expand its vaccination efforts to protect the 25 million people at the highest risk.

Disclaimer of medicaltrend.org